These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4147388)

  • 21. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 22. A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile.
    Charlier R; Bauthier J
    Arzneimittelforschung; 1973 Sep; 23(9):1305-11. PubMed ID: 4801226
    [No Abstract]   [Full Text] [Related]  

  • 23. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R; Karim F; Stoker JB; Harry JD
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract]   [Full Text] [Related]  

  • 24. [Specific differences between the adrenergic beta receptors of the heart and coronary vessels].
    Bayer BL; Mentz P; Förster W
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):341-7. PubMed ID: 4405155
    [No Abstract]   [Full Text] [Related]  

  • 25. Antagonism of cardiac arrhythmias by beta-adrenoreceptor blocking agents.
    Laddu AR; Kumakura S; Somani P
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):168-81. PubMed ID: 4404932
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols.
    Large MS; Smith LH
    J Med Chem; 1980 Feb; 23(2):112-7. PubMed ID: 6102152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
    Masumoto S; Inoue H; Maruyama Y
    Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines.
    Mylecharane EJ; Raper C
    Eur J Pharmacol; 1971 Sep; 16(1):14-20. PubMed ID: 4400509
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
    Lee RJ; Evans DB; Baky SH; Laffan RJ
    Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the myocardial depressant effect of KL 255: a beta adrenergic receptor antagonist.
    Pendleton RG; Petta JM; Hahn RA
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):75-87. PubMed ID: 4394700
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
    Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 May; 20(5):705-8. PubMed ID: 16137
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular studies on different classes of soft drugs.
    Juhász A; Bodor N
    Pharmazie; 2000 Mar; 55(3):228-38. PubMed ID: 10756546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Syntheses of 8-acylamino-3,4-dihydrocarbostyril derivatives with beta-adrenergic blocking action].
    Oshiro Y; Watanabe K; Nakagawa K
    Yakugaku Zasshi; 1984 Jan; 104(1):28-36. PubMed ID: 6145784
    [No Abstract]   [Full Text] [Related]  

  • 37. Protection of CGS 10078B against ouabain-induced arrhythmia in the cat.
    Lathers CM; Tumer N; Frame V; Roberts J
    Pharmacology; 1987; 35(1):35-46. PubMed ID: 2888137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on new beta-adrenergic blocking agents. II. Syntheses and pharmacology of 2-anilinotropone derivatives.
    Sato Y; Tanaka T; Kumakura S; Koike H; Oshima T
    Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):514-22. PubMed ID: 4153810
    [No Abstract]   [Full Text] [Related]  

  • 40. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.